Publications

  1. Butensky SD, Bansal VV, Su DG, Waheed MT, Nikiforchin A, Gomez-Mayorga JL, Olecki E, Radomski SN, Sun B, Turaga KK, Gunderson CG, Lacy J, Badgwell BD, In H, Kennedy T, Yoon HH, Greer JB, Sundar R, Woo Y, Peritoneal Surface Malignancies Consortium Group. Consensus guideline for the management of gastric cancer with synchronous peritoneal metastases. Cancer. 2025 Jul 1; 131 (13):e35870
    View PubMed
  2. Su DG, Brown LM, Bansal VV, Bakkila B, Concors SJ, Turaga KK, Gunderson C, Bergsland E, Strosberg JR, Halfdanarson TR, Metz DC, Kunstman JW, Kunz PL, Gangi A, Peritoneal Surface Malignancies Consortium Group. Consensus guideline for the management of peritoneal metastases from neuroendocrine neoplasms. Cancer. 2025 Jul 1; 131 (13):e35871
    View PubMed
  3. Fecho K, Glusman G, Baranzini SE, Bizon C, Brush M, Byrd W, Chung L, Crouse A, Deutsch E, Dumontier M, Foksinska A, Hadlock J, He K, Huang S, Hubal R, Hyde GM, Israni S, Kenmogne K, Koslicki D, Marcette JD, Mathe EA, Mesbah A, Moxon SAT, Mungall CJ, Osborne J, Pasfield C, Qin G, Ramsey SA, Reese J, Roach JC, Rose R, Soman K, Su AI, Ta C, Vaidya G, Weber R, Wei Q, Williams M, Wu C, Xu C, Yakaboski C, Biomedical Data Translator Consortium. Announcing the Biomedical Data Translator: Initial Public Release. Clin Transl Sci. 2025 Jul; 18 (7):e70284
    View PubMed
  4. Su DG, Brown LM, Bansal VV, Bakkila B, Concors SJ, Turaga KK, Gunderson C, Bergsland E, Strosberg JR, Halfdanarson TR, Metz DC, Kunstman JW, Kunz PL, Gangi A, Peritoneal Surface Malignancies (PSM) Consortium Group. Consensus Guideline for the Management of Peritoneal Metastases from Neuroendocrine Neoplasms. Ann Surg Oncol. 2025 Jun 25 Epub 2025 June 25
    View PubMed
  5. Butensky SD, Bansal VV, Su DG, Waheed MT, Nikiforchin A, Gomez-Mayorga JL, Olecki E, Radomski SN, Sun B, Turaga KK, Gunderson CG, Lacy J, Badgwell BD, In H, Kennedy T, Yoon HH, Greer JB, Sundar R, Woo Y, Peritoneal Surface Malignancies (PSM) Consortium Group. Consensus Guideline for the Management of Gastric Cancer with Synchronous Peritoneal Metastases. Ann Surg Oncol. 2025 Jun 25 Epub 2025 June 25
    View PubMed
  6. Farris J, Dergam-Larson C, Lopour M, Darr K, Schimmenti LA, Scruggs BA, Lambert LJ, Klee EW. A case of congenital heart defects and familial exudative vitreoretinopathy caused by activation of a cryptic splice donor in NOTCH1. BMC Med Genomics. 2025 May 26; 18 (1):94
    View PubMed
  7. Pinto E Vairo F, Geske JB, Singh RJ, Dyer RB, Siontis KC, O'Connell M, Schmitz C, Lambert L, Clark KJ, Raymond KM, Maleszewski JJ, Wood T, Pichurin PN, Klee EW, Pereira NL. Mucopolysaccharidosis Type IIIA Presenting as Hypertrophic Cardiomyopathy. Circ Heart Fail. 2025 Mar 31; e012632. [Epub ahead of print]
    View PubMed
  8. Ruff SM, Kasumova G, Palavalli M, Eng OS, Lambert L, Clarke C, Patel S, Veerapong J, Fournier K, Abbott D, Staley C, Grotz T, Johnston F, Raoof M, Dineen S, Cloyd JM, Kim AC. Long term outcomes associated with the use of perioperative systemic chemotherapy on low grade appendiceal mucinous neoplasms with pseudomyxoma peritonei treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Front Oncol. 2024; 14:1456920 Epub 2025 Jan 09
    View PubMed
  9. Joseph R, Robinson ML, Lambert L, Srivastava OP. Lens-specific betaA3/A1-conditional knockout mice: Phenotypic characteristics and calpain activation causing protein degradation and insolubilization. PLoS One. 2023; 18 (3):e0281386 Epub 2023 Mar 29
    View PubMed
  10. Leier A, Moore M, Liu H, Daniel M, Hyde AM, Messiaen L, Korf BR, Selvakumaran J, Ciszewski L, Lambert L, Foote J, Wallace MR, Kesterson RA, Dickson G, Popplewell L, Wallis D. Targeted exon skipping of NF1 exon 17 as a therapeutic for neurofibromatosis type I. Mol Ther Nucleic Acids. 2022 Jun 14; 28:261-278 Epub 2022 Mar 15
    View PubMed
  11. Awad EK, Moore M, Liu H, Ciszewski L, Lambert L, Korf BR, Popplewell L, Kesterson RA, Wallis D. Restoration of Normal NF1 Function with Antisense Morpholino Treatment of Recurrent Pathogenic Patient-Specific Variant c.1466A>G; p.Y489C. J Pers Med. 2021 Dec 7; 11 (12) Epub 2021 Dec 07
    View PubMed
  12. Voskobiynyk Y, Battu G, Felker SA, Cochran JN, Newton MP, Lambert LJ, Kesterson RA, Myers RM, Cooper GM, Roberson ED, Barsh GS. Aberrant regulation of a poison exon caused by a non-coding variant in a mouse model of Scn1a-associated epileptic encephalopathy. PLoS Genet. 2021 Jan; 17 (1):e1009195 Epub 2021 Jan 07
    View PubMed
  13. Wallis D, Ke H, Tuner AN, Lambert LJ, Yoder BS, Moore JF, Sharer JD, Yang K, Yang Q@, Johnson MS, Smith DL, Nagy TR, Brosius SN, Schoeb TR, Bradley K, Huang F, Korf BR, Anastasaki C, Gutmann DH, Kesterson RA. GABAergic and Systemic Deletion of Neurofibromin Induces Complex Metabolic and Behavioral Phenotypes Cell Metabolism. 2021.
  14. Lambert LJ, Johnson LW, Kennedy D, Cadillac J, Kesterson RA. Improved Oviduct Transfer Surgery for Genetically Modified Rat Production. Bio Protoc. 2017 Aug 20; 7 (16)
    View PubMed
  15. Kesterson RA, Johnson LW, Lambert LJ, Vivian JL, Welch DR, Ballinger SW. Generation of Mitochondrial-nuclear eXchange Mice via Pronuclear Transfer. Bio Protoc. 2016 Oct 20; 6 (20)
    View PubMed
  16. Lambert LJ, Challa AK, Niu A, Zhou L, Tucholski J, Johnson MS, Nagy TR, Eberhardt AW, Estep PN, Kesterson RA, Grams JM. Increased trabecular bone and improved biomechanics in an osteocalcin-null rat model created by CRISPR/Cas9 technology. Dis Model Mech. 2016 Oct 1; 9 (10):1169-1179 Epub 2016 July 28
    View PubMed
  17. Xue X, Mutyam V, Tang L, Biswas S, Du M, Jackson LA, Dai Y, Belakhov V, Shalev M, Chen F, Schacht J, J Bridges R, Baasov T, Hong J, Bedwell DM, Rowe SM. Synthetic aminoglycosides efficiently suppress cystic fibrosis transmembrane conductance regulator nonsense mutations and are enhanced by ivacaftor. Am J Respir Cell Mol Biol. 2014 Apr; 50 (4):805-16
    View PubMed